HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Color Me Beautiful stepping up production of Flori Roberts, Iman prestige ethnic brands.

This article was originally published in The Rose Sheet

Executive Summary

COLOR ME BEAUTIFUL ENTERS ETHNIC PRESTIGE MARKET WITH FLORI ROBERTS acquisition, as well as the purchase of Patti LaBelle and Iman from IVX Biosciences (Ivax). Under the deal announced July 14, Chantilly, Va.-based Color Me Beautiful will assume ownership and operations for the ethnic skin care, cosmetics and fragrance brands. The deal represents a logical fit for Color Me Beautiful because it broadens the firm's presence into the ethnic arena within its established line of distribution. Color Me Beautiful cosmetics generate 80% of company sales in the same department store doors as the former IVX brands. The brands are distributed in approximately 18 department store chains, including J.C. Penney and Carson Pirie Scott, as well as May Company and Federated stores.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel